FDA — authorised 28 March 1997
- Application: NDA020570
- Marketing authorisation holder: LANTHEUS MEDICAL
- Local brand name: QUADRAMET
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Samarium 153 in United States
FDA authorised Samarium 153 on 28 March 1997
Marketing authorisation
Samarium 153 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Samarium 153 approved in United States?
Yes. FDA authorised it on 28 March 1997.
Who is the marketing authorisation holder for Samarium 153 in United States?
LANTHEUS MEDICAL holds the US marketing authorisation.